For Germany, the current status is: Mysimba is currently not on the market
Payment warning: Consultation fees are generally non-refundable after provider review
"The real danger is that while they might not experience harmful effects now, in the long run they'll be increasing their risk of skin cancer." As nasal tanners are not a medicinal product they do not have to be authorised, approved or registered by the MHRA before being sold
Indeed, the suggestion of possible cardiovascular benefit seen in the safety studies is now being formally examined in large randomized-controlled trials with primary cardiovascular end points
Nutritional considerations with anti-obesity medications
A NutraShure white paper , The Potential of Butyrate for Endogenous GLP-1 Secretion , takes a deep dive into the connection between butyrate, a short-chain fatty acid produced in the gut, and its role in enhancing glucagon-like peptide-1 (GLP-1) production